Zhejiang Huahai Pharmaceutical Company Profile - Aug 13, 2011 by WrightReports

VIEWS: 79 PAGES: 10

ZHEJIANGHUAHAIPHARMACEUTICALCO.,LTD is principally engaged in the manufacture and distribution of pharmaceutical ingredients, intermediates and preparations. The Company's major products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine hydrochloride tablets, risperidone tablets, fosinopril sodium tablets and irbesartan and hydrochlorothinzide tablets, among others. The Company also involves in provision of related technical support services. The Company distributes its products in domestic and overseas markets.

More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Zhejiang Huahai Pharmaceutical
                                                                                      440 Wheelers Farms Road
                                                                                      Milford, CT 06461 U.S.A.


  COMPANY PROFILE
  Figures in Chinese Renmimbi

                                  Wright Quality Rating:BAB8                               Key Data

   ZHEJIANGHUAHAIPHARMACEUTICALCO.,LTD is principally engaged in the manufacture           Ticker:
   and distribution of pharmaceutical ingredients, intermediates and preparations. The     600521
   Company's major products are classified as -pril series, -sartan series and
   preparations, including irbesartan tablets, paroxetine hydrochloride tablets,           2010 Sales:
   risperidone tablets, fosinopril sodium tablets and irbesartan and hydrochlorothinzide
                                                                                           1,022,845,000
   tablets, among others. The Company also involves in provision of related technical
   support services. The Company distributes its products in domestic and overseas
   markets.                                                                                Major Industry:
                                                                                           Drugs, Cosmetics & Health
                       Stock Chart                                  Officers
                                                                                           Care
                                                               Chairman & General
                                                                    Manager
                                                                  Baohua Chen              Sub Industry:
                                                                                           Ethical Drug Manufacturers
                                                                 Vice Chairman
                                                                     Jun Du                Country:
                                                                                           China

                                                                                           Currency:
                                                                                           Chinese Renmimbi

                                                                                           Fiscal Year Ends:
                                                                                           December

                                                                                           Employees
                                                                                           2,855

                                                                                           Exchanges:
                                                                                           SHG
             Stock Price (8/5/2011): 15.46
               Recent stock performance                                                    Share Type:
                   1 Week      -5.3%                                        
								
To top